Back to Agenda
GVP Module XVI - Risk minimisation measures: Selection of tools and effectiveness indicators (REV 3)- cont.
Speaker(s)
METHODS FOR EFFECTIVENESS EVALUATION OF RISK MINIMISATION MEASURES (RMMs)
Thomas Goedecke, PharmD, PhD
European Medicines Agency, Netherlands
Senior Pharmacovigilance Specialist
MONITORING THE EFFECTIVENESS OF RMMs: FROM THEORY TO PRACTISE
Daniel Morales, MD, PhD, MRCP
University of Dundee, United Kingdom
Member PRAC, Pharmacovigilance and Epidemiology Department
Q&A AND PANEL DISCUSSION INCLUDING:
Priya Bahri, PhD, RPh
European Medicines Agency, Netherlands
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy)
Q&A AND PANEL DISCUSSION INCLUDING:
Viola Macolic Sarinic, DrSc, MD, MSc
European Medicines Agency, Netherlands
PRAC Scientific Lead
Have an account?